Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965581 | Vaccine | 2014 | 6 Pages |
Abstract
New vaccines are required to meet the public health challenges of the next generation and many unmet global health needs can be addressed by developing countries vaccine manufacturers such as lower-cost vaccines based on single-dose, thermostable formulations, efficacious in children with compromised gastrointestinal tracts. GMP compliance is also a challenge, as sometimes innovation and clinical development focus is not accompanied by command of scale-up and quality assurance for large volume manufacturing and supply. Identifying and addressing such challenges, beyond cost and cold-chain space, including safety considerations and health worker behavior, regulatory alliances and harmonization to foster access to vaccines, will help countries to ensure sustainable immunization. There needs to be continuous and close management of the global vaccine supply both at national and international levels, requiring careful risk management, coordination and cooperation with manufacturers. Successful partnership models based on sharing a common goal, mutual respect and good communication were discussed among stakeholders.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sonia Pagliusi, Patrick Tippoo, Venkatraman Sivaramakrishnan, Thuvan Nguyen, DCVMN Executive Committee DCVMN Executive Committee,